Limbas, Rotchel P.

HRN: 06-38-31  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
CEFUROXIME 1.5GM (VIAL)
06/11/2022
06/11/2022
IV
1.5g
Once
For THBS (prophylaxis)
Waiting Final Action 
06/13/2022
CEFUROXIME 1.5GM (VIAL)
06/13/2022
06/14/2022
IV
1.5grams
Q8H
S/P THBSO
Waiting Final Action 
06/13/2022
CEFUROXIME 1.5GM (VIAL)
06/13/2022
06/14/2022
IV
1.5grams
Q8H
S/P THBSO
Waiting Final Action 
06/14/2022
CEFUROXIME 500MG (TAB)
06/14/2022
06/20/2022
PO
500mg
BID
S/p Hysterectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: